ACADM and medium chain acyl-CoA dehydrogenase deficiency: The implementation of expanded newborn screening programs reduced mortality and morbidity in medium-chain acyl-CoA dehydrogenase deficiency (MCADD) caused by mutations in the ACADM gene.